Advanced Biomed Inc. ADVB
NASDAQ
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 695.00K | -488.90K | -386.90K | -386.90K | -701.60K |
| Total Depreciation and Amortization | -44.50K | 9.30K | 48.00K | 48.00K | -68.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -820.60K | 0.00 | 100.00 | 100.00 | -3.77M |
| Change in Net Operating Assets | -413.20K | 239.80K | -271.50K | -271.50K | 3.00M |
| Cash from Operations | -583.30K | -239.80K | -610.30K | -610.30K | -1.54M |
| Capital Expenditure | 15.90K | -1.30K | -1.80K | -1.80K | 11.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -2.58M | -- | -- | -- | -- |
| Other Investing Activities | 75.80K | -- | -- | -- | -31.70K |
| Cash from Investing | -2.49M | -1.30K | -1.80K | -1.80K | -20.10K |
| Total Debt Issued | 936.80K | 2.30K | 458.70K | 458.70K | -488.90K |
| Total Debt Repaid | -- | 17.90K | -11.20K | -11.20K | 1.20K |
| Issuance of Common Stock | 0.00 | 248.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -108.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -- | -- | -169.20K |
| Cash from Financing | 936.80K | 268.30K | 447.50K | 447.50K | -765.50K |
| Foreign Exchange rate Adjustments | -86.40K | -29.20K | -82.70K | -82.70K | 49.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.22M | -2.00K | -247.40K | -247.40K | -2.28M |